YOLFTbeta
Cathay Biotech Inc

Cathay Biotech Inc

688065 · SHG · Basic Materials / Chemicals

36.75CNY-0.98 (-2.60%)

Price History

Full chart

Market Stats

Previous Close37.73
Open37.62
Day Range36.70 – 38.12
52-Week Range36.91 – 63.85
Volume2.67M
Market Cap27.87B
P/E (TTM)44.41
Forward P/E0.00
EPS0.87
Dividend Yield1.16%
Beta0.41
50-Day Avg42.51
200-Day Avg47.92

About

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company's products are used in textiles, pharmaceuticals, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEODr. Xiucai Liu
  • Employees1.84K
  • HeadquartersBuilding 11, Shanghai, China, 201114, China
  • Websitehttps://www.cathaybiotech.com

Leadership

  • Dr. Xiucai LiuChairman & President · b. 1957
  • Ms. Huiqing ZangVP, Secretary of the Board of Directors & Vice Chairman · b. 1974
  • Mr. Chen YangVP, Core Technician, COO & Director · b. 1985
  • Mr. Yijun DuVice President · b. 1965
  • Mr. Jun ZuoVice President · b. 1979
  • Mr. Hong Guang ZhangVice President · b. 1968
  • Mr. Benliang HouVice President · b. 1967
  • Xiao Kun ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue929.13M1.36B1.76B1.92B1.50B2.36B2.44B2.11B2.96B3.30B
Growth (%)-+46.66%+28.94%+9.05%-21.87%+57.86%+3.28%-13.39%+39.91%+11.41%
Cost of Revenue594.76M772.47M993.90M1.07B808.77M1.53B1.61B1.53B2.12B2.66B
Gross Profit334.37M590.22M763.22M851.14M688.42M837.21M829.20M579.23M836.44M635.09M
Gross Margin35.99%43.31%43.44%44.42%45.98%35.42%33.97%27.40%28.28%19.27%
Operating Expense129.29M184.38M222.15M262.09M166.19M113.86M120.92M124.93M284.88M0
Operating Income205.07M405.84M541.07M589.06M522.23M723.35M708.28M454.30M551.56M635.09M
Operating Margin22.07%29.78%30.79%30.74%34.88%30.61%29.01%21.49%18.65%19.27%
EBITDA201.71M439.74M617.15M689.73M643.28M909.28M985.74M772.51M897.41M947.42M
EBITDA Margin21.71%32.27%35.12%35.99%42.97%38.47%40.38%36.54%30.34%28.75%
Net Income145.47M332.73M466.29M478.88M457.67M594.72M553.27M366.52M488.96M565.72M
Net Income Margin15.66%24.42%26.54%24.99%30.57%25.16%22.66%17.34%16.53%17.17%
R&D37.52M64.56M86.39M90.16M84.30M133.53M187.71M189.13M233.34M237.89M
R&D as % of Total Revenue4.04%4.74%4.92%4.71%5.63%5.65%7.69%8.95%7.89%7.22%
Interest Expense-640.14K3.87M17.58M4.17M16.29M24.62M37.87M33.47M8.79M
Interest Expense % of Total Revenue-0.05%0.22%0.92%0.28%0.69%1.01%1.79%1.13%0.27%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.66B3.13B4.84B5.98B12.14B16.20B17.83B18.83B19.02B23.88B
Total Liabilities439.21M936.58M1.68B1.34B650.74M1.51B2.79B4.06B3.92B-21.22B
Total Equity1.22B2.20B3.16B4.64B10.38B10.67B10.95B11.16B11.51B21.22B
Cash349.63M135.14M242.78M366.38M5.71B9.63B6.29B5.39B5.35B9.25B
Total Debt-77.08M128.00M300.24M-743.51M1.13B1.78B1.86B-
Net Debt-349.63M-58.06M-114.78M-66.13M-5.71B-8.89B-5.17B-3.61B-3.49B-

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-128.67M53.45M-10.29M359.62M514.96M594.18M803.67M569.45M820.93M404.12M
Investing Cash Flow104.44M-1.00B-587.60M-1.21B-1.20B-126.25M-4.20B-1.56B-823.06M-
Financing Cash Flow-68.36M715.39M645.10M1.05B6.06B2.99B403.88M-262.16M149.49M-
Capital Expenditure323.34M995.09M410.08M511.14M763.11M1.47B4.20B1.57B843.31M743.46M
Free Cash Flow-452.02M-941.64M-420.37M-151.52M-248.15M-880.49M-3.39B-1.00B-22.38M-339.34M
Dividends Paid-95.00K178.82M121.34M3.87M333.35M187.30M104.79M140.83M313.13M
FCF to OCF351.29%-1761.86%4086.56%-42.13%-48.19%-148.19%-422.40%-175.67%-2.73%-83.97%
Dividend Paid to FCF--0.01%-42.54%-80.08%-1.56%-37.86%-5.52%-10.48%-629.18%-92.28%

Earnings

Report DateOct 26, 2020Mar 29, 2021Apr 26, 2021Aug 18, 2021Oct 28, 2021Feb 26, 2022Apr 26, 2022Aug 12, 2022Oct 27, 2022Feb 27, 2023Apr 26, 2023Aug 7, 2023
EPS Estimate------------
EPS Actual0.210.230.240.320.280.200.300.280.250.120.100.32
Surprise------------
TimingAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap27.87B
Enterprise Value19.77B
Trailing P/E44.41
Forward P/E0.00
Price / Sales7.91
Price / Book1.60
EPS0.87
Book Value24.91
Revenue (TTM)3.52B
Gross Profit (TTM)1.15B
EBITDA971.98M
Profit Margin17.73%
Operating Margin17.78%
Return on Equity2.88%
Return on Assets1.71%
Shares Outstanding721.29M
Shares Float299.75M
Beta0.41
Dividend Yield1.16%
Dividend Rate0.45
Payout Ratio45.98%

Dividends

20261×
0.45Jul 29, 2026
20251×
0.40Aug 1, 2025
20241×
0.19Jul 24, 2024
20231×
0.18Jul 18, 2023
20221×
0.45Jul 20, 2022
20211×
0.57Jul 27, 2021

Stock Splits

  • Jul 20, 20221.4:1